[174 Pages Report] According to Future Market Insights (FMI), the global western blotting market is expected to expand at close to 6.0% CAGR during the forecast period of 2021 to 2031.
Western blotting, being the gold standard and confirmatory test for HIV diagnosis, is gaining traction around the world. As the increase in applications in diverse fields such as agriculture, diagnostics, life science research, to name a few, tends to persist, manufacturers operating in this industry are getting more inclined to bring in wider variety of products. The updated edition of Future Market Insights’ study tracks growth in over 20+ markets, covering the regulatory framework as well as strategies of leading players.
Rise in prevalence of AIDS coupled with the increase in research & development (R&D) activities in proteomics field continues to drive adoption of western blotting industry. According to the report titled “Global HIV & AIDS Statistics- 2020 Fact Sheet” published by the UNAIDS Organization, 38 million people globally were living with HIV in 2019, while 75.7 million people have become infected with HIV since the start of the epidemic (end 2019). These data represent the unlimited opportunities awaiting for suppliers and manufacturers in western blotting industry.
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1050
Key Takeaways from Study
- Electrophoresis blotting systems remain the preferred product type
- Surge in demand from pharmaceutical and biotechnology sectors to fuel sales of western blotting products
- Growing application in scientific research to favor stakeholders in western blotting industry
- US will remain the most lucrative market for western blotting globally
- Germany to maintain the lead in the world’s second largest western blotting market Europe
- Asia-Pacific to witness the fastest growth rate, while being led by China, India, and Japan
- The United Kingdom, France, Canada, Italy, and a few other countries remain lucrative for western blotting product manufactures
“Rise in scientific research activities in proteomics, a rapidly growing field of molecular biology, is subject to cater to the steady expansion of the global western blotting market. Furthermore, increase in governmental investments in pharmaceutical & biotechnology sectors is expected to further cater to the growth of western blotting industry,” says an FMI analyst.
Rise in Awareness Regarding Early Diagnosis of HIV Aiding Growth
Western blotting is highly efficient in separating the blood proteins and detecting the specific proteins called HIV antibodies in diagnosis of HIV or AIDS. According to a report published by the HIV Government on 25th November, 2020, about 81% of people with HIV worldwide have been tested and know their HIV status. As per the report, an estimated 1.7 million individuals worldwide acquired HIV in 2019, marking a 23% decline in new HIV infections since 2010. While these figures represent the growing awareness, it also indicates the increase in requirement for western blotting products since the past decade.
As stated in the global statistics report published by the HIV Government, AIDS-related deaths have been reduced by 60% since the peak in 2014, while in 2019, around 690,000 people died from AIDS-related illness worldwide, compared to 1.1 million in 2010. As per the report, the global commitment to stop new HIV infections and ensuring that everyone has access to HIV diagnosis & treatment is bound to yield positive results. This also implies the surge in demand for western blotting products in the coming years.
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1050
Who is Winning in this Space?
The global western blotting market offers remains fiercely competitive. In order to consolidate their position, key market players are launching wide variety of western blotting solutions.
For instance,
- Thermo Fisher Scientific, Inc. launched its new range of western blotting products such as Thermo Fisher Electrophoresis Buffers and Reagents, Cell Lysis Buffers, Fluorescent Detection Solutions, and others a couple of years back
- GE Healthcare launched its range of New Amersham™ WB System for Reproducible and Quantitative Protein Analysis, and other Western Blotting Solutions during 2014 to 2020
More Valuable Insights
In its latest report, FMI offers unbiased analysis of the global western blotting market, providing historical data for the period of 2016-2020 and forecast statistics for 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (electrophoresis blotting systems (automated dry blotting systems, semi-dry blotting systems, and traditional wet transfer blotting systems), and reagent kits (chromogenic reagent kits, chemiluminescent reagents kits (Horseradish Peroxidase (HRP) substrate, and Alkaline Phosphatase (AP) substrate), fluorescent reagents, antibodies (primary antibody, and secondary antibody), and buffer kits)), application (scientific research, medical diagnostics, agriculture, food & beverages, and others), and end use (diagnostic laboratories, research institutions, pharmaceutical & biotechnology companies), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).
For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1050
Western Blotting Market Segmentation by Category
Product Type
- Electrophoresis Blotting Systems
- Automated Dry Blotting Systems
- Semi-Dry Blotting Systems
- Traditional Wet Transfer Blotting Systems
- Reagent Kits
- Chromogenic Reagent Kits
- Chemiluminescent Reagent Kits
- Horseradish Peroxidase (HRP) Substrate
- Alkaline Phosphatase (AP) Substrate
- Fluorescent Reagents
- Antibodies
- Primary Antibody
- Secondary Antibody
- Buffer Kits
Application
- Research
- Diagnostics
- Agricultural
- Food & Beverages
- Other Applications
End User
- Diagnostic Laboratories
- Research Institutions
- Pharmaceutical & Biotechnology Companies
Region
- North America
- Latin America
- Europe
- Middle East and Africa (MEA)
- East Asia
- South Asia
- Oceania
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.